First human test of potential enterovirus drug begins
NCT ID NCT06444048
Summary
This is an early safety study of a new drug called EV68-228-N, which is being developed to treat enterovirus infections. The study enrolled 36 healthy adult volunteers to test three different doses of the drug, given as a single infusion into a vein. The main goals are to see if the drug is safe and to measure how long it stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROVIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Baltimore, Maryland, 21201-1509, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-0011, United States
Conditions
Explore the condition pages connected to this study.